Director - HEOR Evidence Synthesis
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
The Director, HEOR Evidence Synthesis is a pivotal role within the HEOR Evidence Synthesis and Strategy (HEOR-ESS) sub-team at Novo Nordisk, located in Princeton, NJ. This position is responsible for leading the HEOR evidence synthesis efforts, ensuring that both internally and externally generated HEOR evidence is effectively utilized to support the pre-launch, launch, and life-cycle management of therapies. The HEOR-ESS sub-team operates under the larger Clinical Data Science and Evidence (CDSE) team within the Clinical, Medical and Regulatory (CMR) department, which is known for its diversity and collaborative spirit. The overarching mission of the HEOR-ESS team is to develop a comprehensive HEOR evidence strategy that aligns with the broader organizational strategy, while synthesizing and disseminating impactful real-world evidence produced by the Real-World Evidence (RWE) and modeling teams within CDSE. In this role, the Director will collaborate closely with the HEOR Strategy Director to ensure that stakeholder evidence needs, whether related to RWE or modeling, are integrated into the HEOR strategy. The evidence generated must be scientifically rigorous and aligned with Novo Nordisk's strategic objectives throughout the product life cycle. The Director will also engage with external organizations such as the Institute for Clinical and Economic Review (ICER) to conduct health technology assessments of Novo Nordisk products in the U.S. Additionally, the incumbent will serve as an internal reviewer and approver of research protocols, facilitating the effective communication of synthesized evidence to external customers, including the development of materials for both proactive promotion and reactive medical exchanges. The Director will lead the execution and dissemination of rapid data analytics requests from stakeholders, supporting their internal strategies. This role requires high visibility within a matrixed environment, working alongside various functions such as HEOR Strategy, Market Access, Medical Affairs, and Clinical Development. The Director will be responsible for conceptualizing and delivering the Evidence Synthesis Package and other creative evidence deliverables as required by stakeholders. The key deliverable for this position is the synthesis and dissemination of compelling evidence that meets the needs of decision-makers and aligns with Novo Nordisk's evidence requirements and research strategy.
